Cargando…
Interpreting Effect Sizes and Clinical Relevance of Pharmacological Interventions for Fibromyalgia
Duloxetine, milnacipran, and pregabalin are approved by the United States Food and Drug Administration for the management of fibromyalgia. A number of meta-analyses, pooled analyses, and systematic reviews have been published in recent years involving the efficacy of these three medications for pain...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107878/ https://www.ncbi.nlm.nih.gov/pubmed/25135038 http://dx.doi.org/10.1007/s40122-013-0011-1 |